Illumina (ILMN) Convertible Debt (2011 - 2022)

Illumina (ILMN) posted quarterly Convertible Debt of $746.0 million for Q2 2022, up 9.71% year-over-year from $680.0 million in Q2 2021, and up 6.27% on a QoQ basis from $702.0 million in Q1 2022.

Illumina (ILMN) Convertible Debt (2011 - 2022) Analysis & Trends

Illumina has reported Convertible Debt for 7 years, with the latest figure at $746.0 million in Q2 2022.

  • Convertible Debt for Q2 2022 came in at $746.0 million, up 9.71% year-over-year; the trailing twelve-month figure through Apr 2022 was $746.0 million (up 9.71% YoY), and the FY2022 annual result was $702.0 million, up 4.31% from the prior year.
  • Convertible Debt advanced to $746.0 million in Q2 2022, from $702.0 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $746.0 million in Q2 2022 and troughed at $673.0 million in Q1 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.92 Bn 209.86 Bn 8.34 Bn
2 Danaher 140.37 Bn 136.02 Bn 3.61 Bn
3 Idexx Laboratories 46.17 Bn 45.97 Bn 779.09 Mn
4 Agilent Technologies 39.76 Bn 37.96 Bn 990.00 Mn
5 Iqvia Holdings 39.41 Bn 37.33 Bn 1.44 Bn
6 Natera 38.75 Bn 37.65 Bn 696.04 Mn
7 Illumina 30.07 Bn 28.90 Bn 770.00 Mn
8 Mettler Toledo International 28.62 Bn 28.56 Bn 650.22 Mn
9 Quest Diagnostics 26.15 Bn 25.53 Bn 1.03 Bn
10 Labcorp Holdings 25.87 Bn 24.89 Bn 1.01 Bn

Historic Data

Download Data
DateValue
Apr 3, 2022 746.00 Mn
Jan 2, 2022 702.00 Mn
Oct 3, 2021 694.00 Mn
Jul 4, 2021 687.00 Mn
Apr 4, 2021 680.00 Mn
Jan 3, 2021 673.00 Mn
Jun 28, 2015 1.00 Bn
Mar 29, 2015 993.78 Mn
Dec 28, 2014 986.78 Mn
Sep 28, 2014 979.84 Mn
Jun 29, 2014 972.95 Mn
Dec 29, 2013 839.31 Mn
Sep 29, 2013 830.69 Mn
Jun 30, 2013 822.17 Mn
Mar 31, 2013 813.74 Mn
Dec 30, 2012 805.41 Mn
Sep 30, 2012 797.16 Mn
Jul 1, 2012 789.01 Mn
Apr 1, 2012 780.94 Mn
Jan 1, 2012 807.37 Mn